A 24-moth clinical e-cig study published in the February edition of Regulatory Toxicology and Pharmacology found no negative health impact on users, despite regular vaping.

Examining 209 smokers who volunteered to use a standard closed-system vaping device for 24 months, experts monitored for adverse events, lung functionality, electrocardiogram results and exposure to nicotine and tobacco constituents.

The study was entitled “Evaluation of the Safety Profile of an Electronic Vapour Product Used for Two Years by Smokers in a Real-life Setting”.

Another recent study from an Indian University found that e-cigs are less harmful than traditional cigarettes.

No serious concerns of participants were recorded. The use of vaping products actually saw a reduction in nicotine withdrawal symptoms, less exposure to properties of cigarette smoke and no cases of weight-gain.

“Clinical data over a two-year period gives us a much clearer picture about longer term vaping, and the potential implications for the health of smokers, so they can make an informed decision,” said Tanvir Walele, Director of Scientific Affairs at Fontem Ventures and owner of an e-cigarette brand.

“Governments and policy-makers should ensure that regulatory frameworks reflect this emerging scientific consensus, as more long term research demonstrates the safety profile of e-cigarettes,” said Walele. “This research suggests we need e-cigarette regulation that is not modelled on tobacco product regulation, but encourages innovation and compliance with robust product quality, manufacturing and safety standards.”

For far more detail on the study, you see the findings at EurekAlert!.